Whether you are looking to introduce single-use manufacturing components into your current process or investigating how you can implement a single-use process train, Mobius® products and solutions can help you meet your changing manufacturing requirements.
Increased operational flexibility
Reduced capital investment in facilities and equipment
Reduced set-up time
Elimination of CIP and SIP requirements
Reduced validation
Reduced risk of contamination
There are now new biomanufacturing market dynamics, such as increasing competition from biosimilars and rapidly changing drug demands in terms of product type and volumes. These are reshaping how drugs are produced and will result in a facility of the future that is enabled to conduct intensified, connected and continuous bioprocessing.
The BioContinuum™ Platform is Merck's solution to these trends. Our single-use solutions and systems help you achieve continuous, intensified, predictive and autonomous bioprocessing, ultimately with the aim of expanding patient access to affordable life-saving and life-enhancing biotherapeutics.
This is how we envision advanced processing and automation models to provide you with maximum safety, control, transparency, and repeatability in your manufacture of biotherapeutics.